You are here: All Products  > Jemincare Out-Licenses Prostate Cancer Candidate to Genentech for $650 Million

Jemincare Out-Licenses Prostate Cancer Candidate to Genentech for $650 Million

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.